SCHEMBL6506767

SCHEMBL6506767

CCCOc1ccc(-n2cc(NC(N)=O)c(C(N)=O)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.48
PARP1 P09874 5/20 0.41
DGAT1 O75907 1/20 0.41
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP19A1 P11511 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6502166 0.84 MAPT (0.46) ITKKDM4EHTTSMN1; SMN2ALDH1A1
SCHEMBL6504429 0.83 KMT2A (0.49) SMN1; SMN2HDAC1ALDH1A1MAPTTP53
SCHEMBL6501117 0.83 MAPT (0.45) ITKKDM4EHTTSMN1; SMN2ALDH1A1
SCHEMBL6504836 0.82 ITK (0.43) ITKPARP1KDM4EHTTSMN1; SMN2
SCHEMBL6469794 0.80 LMNA (0.47) ITKKDM4EHTTSMN1; SMN2ALDH1A1
SCHEMBL6507055 0.79 ITK (0.53) ITKDGAT1KDM4EHTTSMN1; SMN2
SCHEMBL6500601 0.79 ITK (0.47) ITKKDM4ESMN1; SMN2ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL6466204 0.78 ITK (0.47) ITKALDH1A1MAPTAURKA
SCHEMBL6500092 0.78 KDM4E (0.47) ITKKDM4EHTTSMN1; SMN2ALDH1A1
SCHEMBL6506609 0.78 ITK (0.49) ITKDGAT1KDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885PARP1 1904/4885DGAT1 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.